Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amylin completes application to FDA for metreleptin
Yahoo/Fly on the Wall
Tuesday, April 3, 2012 - 10:10am
tags:
FDA, metreleptin, Amylin, lipodystrophy
Agenus: Buy Or Ready To Bust?
Seeking Alpha
Tuesday, April 3, 2012 - 9:01am
tags:
Agenus, glioma, Prophage
Roche says disappointed by Illumina bid rejection
Reuters
Tuesday, April 3, 2012 - 9:00am
tags:
M&A, Roche, Illumina
3 Anti-Obesity Drug Companies Poised To Grow
Seeking Alpha
Tuesday, April 3, 2012 - 8:59am
tags:
obesity, Vivus, Orexigen, lorcaserin, Arena Pharmaceuticals, Contrave, Qnexa
Another Option Strategy For Vivus
Seeking Alpha
Tuesday, April 3, 2012 - 8:58am
tags:
Vivus, options
Bayer Says Drug Held Off Gastrointestinal Tumors in Study
Bloomberg
Tuesday, April 3, 2012 - 8:57am
tags:
gastrointestinal cancer, Bayer, regorafenib
Map Pharmaceuticals: The Levadex Levitation
Seeking Alpha
Tuesday, April 3, 2012 - 8:56am
tags:
MAP Pharmaceuticals, Levadex, Allergan, migraines
Astellas Overactive Bladder Drug Raises Risks, FDA Staff Says
Bloomberg
Tuesday, April 3, 2012 - 8:54am
tags:
Astellas, overactive bladder, FDA, mirabegron
Astex Pharmaceuticals announces positive clinical data for SGI-110
The Fly on the Wall
Tuesday, April 3, 2012 - 8:53am
tags:
SGI-110, Astex, AML, acute myeloid leukemia
J&J Alzheimer’s Drug May Cut Brain Chemical Tied to Tangles
Bloomberg
Monday, April 2, 2012 - 7:25pm
tags:
Alzheimer's disease, JNJ, bapineuzumab
Amgen, AstraZeneca team on 5 experimental drugs
Marketwatch
Monday, April 2, 2012 - 7:24pm
tags:
Amgen, AstraZeneca, psoriasis, asthma, lupus
Why Novartis Is The Safest Stock In The Pharmaceutical Sector
Seeking Alpha
Monday, April 2, 2012 - 7:23pm
tags:
Novartis, Abbott Laboratories, JNJ, Pfizer
Keryx: Lessons From a Drug Failure
TheStreet.com
Monday, April 2, 2012 - 7:22pm
tags:
Keryx, Aeterna Zentaris, colon cancer, perifosine
Rare-disease drugs won't help out-of-work pharma reps
Fierce Pharma
Monday, April 2, 2012 - 12:24pm
tags:
drug reps, layoffs, orphan drugs
StemCells announces positive preliminary results for Pelizaeus-Merzbacher trial
The Fly on the Wall
Monday, April 2, 2012 - 12:22pm
tags:
StemCells, Pelizaeus-Merzbacher disease
AVI BioPharma tumbles on mixed study results
Marketwatch
Monday, April 2, 2012 - 12:21pm
tags:
AVI BioPharma, Duchenne Muscular Dystrophy, eteplirsen
Illumina Predicts 1Q Sales Will Trump Street
FOX Business
Monday, April 2, 2012 - 12:15pm
tags:
Illumina, guidance, Roche
Novo Nordisk announces FDA approval for Levemir
Yahoo/Fly on the Wall
Monday, April 2, 2012 - 12:03pm
tags:
FDA, pregnancy, Levemir, diabetes, Novo Nordisk
Novo Nordisk to move forward with once-weekly diabetes shot, Bloomberg says
Yahoo/Fly on the Wall
Monday, April 2, 2012 - 12:02pm
tags:
Novo Nordisk, diabetes, Victoza
Merck: Now A Compelling 'Buy' Candidate
Seeking Alpha
Monday, April 2, 2012 - 11:58am
tags:
Merck, M&A, Bayer, GSK, Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.